New Weight Loss Drug, Belviq, Offers New Hope for People With Obesity
(firmenpresse) - SCOTTSDALE, AZ -- (Marketwired) -- 05/07/13 -- The second new weight loss drug in 13 years has just been made available for treatment of obesity. Lorcaserin, which is marketed under the name Belviq®, has been cleared for sale by the FDA last year, and the DEA today. It promises to change the landscape of obesity treatment.
(SWLC) founders, Drs. and , both specialists in obesity treatment, have been anxiously awaiting the availability of this new medication. According to Dr. Ziltzer, "Serotonin is an important factor in hunger. Belviq raises the levels of serotonin in certain areas of the brain that control hunger." Dr. Primack adds, "This is the second new drug to hit the market in over a decade. Obesity is a serious medical disease that warrants serious medical treatment."
The doctors are concerned that the public considers obesity a lack of willpower. Fueled by shows such as Biggest Loser, there is a perception that if you just want to lose weight badly enough, you'll be successful. People can lose 15-20 pounds or less on their own, but losing 20 pounds or more and keeping it off is most successful through the use of specialized diets, appetite suppressants, and a lot of support, according to SWLC physicians.
About Scottsdale Weight Loss Center
(SWLC) is a medical weight management center providing comprehensive weight loss programs to the residents of the Scottsdale, Paradise Valley, Chandler, Tempe, Phoenix, Gilbert and the rest of central Arizona. Founded by and , SWLC provides direct physician-supervised weight loss programs which include custom diets, meal replacements, strong support and education to promote lifelong solutions for managing your weight. Since 2006, SWLC has helped clients lose nearly 105,000 pounds. For more information, visit .
Leigh Luckinbill
9989 N 95th Street
Scottsdale, AZ 85258
480.366.4400
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 07.05.2013 - 20:11 Uhr
Sprache: Deutsch
News-ID 257257
Anzahl Zeichen: 1809
contact information:
Town:
SCOTTSDALE, AZ
Kategorie:
Personal Care & Fitness
Diese Pressemitteilung wurde bisher 306 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"New Weight Loss Drug, Belviq, Offers New Hope for People With Obesity"
steht unter der journalistisch-redaktionellen Verantwortung von
Scottsdale Weight Loss Center (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
